Dallah Healthcare Company (4004.SR)
- Previous Close
120.60 - Open
121.60 - Bid 119.40 x --
- Ask 119.40 x --
- Day's Range
118.60 - 122.00 - 52 Week Range
113.20 - 170.00 - Volume
109,475 - Avg. Volume
111,534 - Market Cap (intraday)
12.036B - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
24.61 - EPS (TTM)
4.82 - Earnings Date May 14, 2025 - May 16, 2025
- Forward Dividend & Yield 2.00 (1.66%)
- Ex-Dividend Date Apr 7, 2025
- 1y Target Est
147.87
Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, and medical polyclinics; and the provision of manpower and support services to hospitals and medical centers. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company engages in the management and operation of hospitals owned by third parties. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was incorporated in 1994 and is based in Riyadh, Saudi Arabia.
www.dallahhealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4004.SR
View MorePerformance Overview: 4004.SR
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4004.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4004.SR
View MoreValuation Measures
Market Cap
12.24B
Enterprise Value
13.98B
Trailing P/E
24.97
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.67
Price/Book (mrq)
3.53
Enterprise Value/Revenue
4.36
Enterprise Value/EBITDA
18.62
Financial Highlights
Profitability and Income Statement
Profit Margin
14.70%
Return on Assets (ttm)
5.51%
Return on Equity (ttm)
13.44%
Revenue (ttm)
3.21B
Net Income Avi to Common (ttm)
471.2M
Diluted EPS (ttm)
4.82
Balance Sheet and Cash Flow
Total Cash (mrq)
166.32M
Total Debt/Equity (mrq)
53.99%
Levered Free Cash Flow (ttm)
-137.56M